| Filed On | Filing |
|---|---|
| 26 Jul 2022 |
8-K/A: Submission of Matters to a Vote of Security Holders
The Annual Meeting of the Company was held on July 15, 2022. Proxies for the Annual Meeting were solicited by the Board of Directors of the Company (the “Board”) pursuant to Section 14(a) of the Securities Exchange Act of 1934, as amende... |
| 25 Jul 2022 |
8-K/A: Submission of Matters to a Vote of Security Holders
The Annual Meeting of the Company was held on July 15, 2022. Proxies for the Annual Meeting were solicited by the Board of Directors of the Company (the “Board”) pursuant to Section 14(a) of the Securities Exchange Act of 1934, as amende... |
| 03 Apr 2015 |
8-K/A: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation
On behalf of AcelRx Pharmaceuticals, Inc. (the “Company”), I am pleased to offer you the position of Interim Chief Executive Officer of the Company. The terms of your new position with the Company are as set forth below: |
| 16 Dec 2014 |
8-K/A: Departure/Election of Directors or Officers; Compensation
This letter contains the terms of the separation agreement (the “Agreement”) which AcelRx Pharmaceuticals, Inc. (the “Company”) is offering to you to assist you in your employment transition. |
Loading...